Shares Rip After Colombia Includes Cannabis Products On List of Mandatory Insurance-Covered Medications

By: Dylan Sikes – AllPennyStocks.com News

Thursday, January 5, 2023

The benefits of medical cannabis are numerous—and this company is on the ground floor to benefit after Colombia is including the product on its list of mandatory insurance-covered medications.

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) announced in its press release that as of the new year, plant-based medical cannabis products will be included in Colombia’s the list of mandatory insurance-covered medications. Khiron also signed a first-of-its-kind medical cannabis contract with one of Colombia’s largest insurance companies.

Beginning on January 1, 2023, every insurance provider in Colombia , is mandated to cover the costs of medical cannabis prescriptions for patients. During the first half of 2022, insurance-covered prescriptions represented more than 90% of Khiron´s cannabis sales in Colombia. With a patient base of more than 25,000 patients, the firm will immediately resume filling insurance-covered prescriptions through its Zerenia clinic network.

Canadian shares of Khiron were trading up sharply at $0.08 in morning trade.

Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.